Form 4 Tracker
Tarsus Pharmaceuticals, Inc.
TARS

43 insider filings · Latest: Jun 25, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 17, 2026Jun 22 8:09 PMBobak R. AzamianDirector, President/CEO and Board Chair
Sale
10,000$61.55$615.5K847,991(I)

View →

Jun 16, 2026Jun 17 8:17 PMJeffrey S FarrowChief Financial Officer and Chief Strategy Officer
Sale
14,396$60.95$877.4K56,801(D)

View →

Jun 15, 2026Jun 17 8:17 PMKatherine GoodrichDirector
Sale
2,954$62.08$183.4K2,233(D)

View →

Jun 15, 2026Jun 17 8:17 PMPhd J Link WilliamDirector
Sale
12,500$62.12$776.5K106,786(D)

View →

Jun 17, 2026Jun 17 6:05 PMBOBAK AZAMIAN
Proposed Sale
10,000$61.55$615.5K

View →

Jun 16, 2026Jun 16 8:53 PMFarrow Jeffrey S
Proposed Sale
14,396$60.95$877.5K

View →

Jun 15, 2026Jun 15 8:58 PMWilliam J Link
Proposed Sale
12,500$62.12$776.5K

View →

Jun 15, 2026Jun 15 3:44 PMGoodrich Katherine
Proposed Sale
2,954$62.08$183.4K

View →

Mar 20, 2026Mar 24 9:05 PMSeshadri NeervannanChief Operating Officer
Sale
2,989$66.75$199.5K82,791(D)

View →

Mar 20, 2026Mar 20 2:38 PMNeervannan Seshadri
Proposed Sale
2,989$66.75$199.5K

View →

Mar 19, 2026Mar 19 11:04 PMDianne C. WhitfieldChief Human Resources Officer
Sale
4,174$67.00$279.7K35,028(D)

View →

Mar 18, 2026Mar 19 11:04 PMDianne C. WhitfieldChief Human Resources Officer
Sale
4,071$68.71$279.7K39,202(D)

View →

Mar 17, 2026Mar 19 11:04 PMDianne C. WhitfieldChief Human Resources Officer
Sale
4,029$69.42$279.7K43,273(D)

View →

Mar 19, 2026Mar 19 11:04 PMBryan WahlGeneral Counsel
Sale
4,231$67.00$283.5K63,959(D)

View →

Mar 18, 2026Mar 19 11:04 PMBryan WahlGeneral Counsel
Sale
4,125$68.71$283.4K68,190(D)

View →

Mar 17, 2026Mar 19 11:04 PMBryan WahlGeneral Counsel
Sale
4,084$69.42$283.5K72,315(D)

View →

Mar 19, 2026Mar 19 11:04 PMSeshadri NeervannanChief Operating Officer
Sale
4,589$67.00$307.5K85,780(D)

View →

Mar 18, 2026Mar 19 11:04 PMSeshadri NeervannanChief Operating Officer
Sale
3,610$68.71$248.0K90,369(D)

View →

Mar 17, 2026Mar 19 11:04 PMSeshadri NeervannanChief Operating Officer
Sale
3,125$69.42$216.9K93,979(D)

View →

Mar 19, 2026Mar 19 11:04 PMAziz MottiwalaChief Commercial Officer
Sale
4,440$67.00$297.5K61,480(D)

View →

Page 1 of 5

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 15, 2026Mar 17 8:24 PMBobak R. AzamianDirector, President/CEO and Board Chair
Option Exercise
66,27444,634(D)

View →

Mar 15, 2026Mar 17 8:20 PMElizabeth Yeu LinChief Medical Officer
Option Exercise
2,5117,534(D)

View →

Mar 5, 2026Mar 9 8:06 PMBryan WahlGeneral Counsel
Grant/Award
44,471$74.9017,161(D)

View →

Mar 5, 2026Mar 9 8:06 PMJeffrey S FarrowChief Financial Officer and Chief Strategy Officer
Grant/Award
50,030$74.9019,306(D)

View →

Mar 5, 2026Mar 9 8:06 PMAziz MottiwalaChief Commercial Officer
Grant/Award
50,030$74.9019,306(D)

View →

Mar 5, 2026Mar 9 8:06 PMSeshadri NeervannanChief Operating Officer
Grant/Award
44,471$74.9017,161(D)

View →

Mar 5, 2026Mar 9 8:06 PMDianne C. WhitfieldChief Human Resources Officer
Grant/Award
44,471$74.9017,161(D)

View →

Mar 5, 2026Mar 9 8:06 PMElizabeth Yeu LinChief Medical Officer
Grant/Award
44,471$74.9017,161(D)

View →

Mar 5, 2026Mar 9 8:06 PMBobak R. AzamianDirector, President/CEO and Board Chair
Grant/Award
157,499$74.9060,776(D)

View →

Feb 18, 2026Feb 20 9:35 PMI E Pyott DavidDirector
Grant/Award
9,622$63.273,729(D)

View →

← Previous

Page 2 of 2